查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1617855

吸入麻醉剂市场：按类型、作用持续时间、应用和最终用途 - 2025-2030 年全球预测

Inhalation Anesthetics Market by Type (Desflurane, Halothane, Isoflurane), Duration of Action (Long-acting, Short-acting), Application, End Use - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年吸入麻醉剂市场价值为17亿美元，预计到2024年将达到18.8亿美元，复合年增长率为11.01%，预计到2030年将达到35.4亿美元。

吸入麻醉剂市场包括各种主要用于外科手术过程中诱导和维持全身麻醉的气体製剂。这些药物包括SEVOFLURANE、DESFLURANE、Isoflurane等，对于确保患者固定、失忆和镇痛至关重要。由于人口老化以及心血管疾病和癌症等慢性疾病盛行率的增加，全世界进行的外科手术数量不断增加，证明了对吸入麻醉剂的需求。这些麻醉剂越来越多地用于牙科手术、兽医手术、门诊病人以及医院和门诊手术中心，扩大了最终用途的范围。

主要市场统计
基准年[2023] 17亿美元
预计年份 [2024] 18.8亿美元
预测年份 [2030] 35.4亿美元
复合年增长率（%） 11.01%

市场成长受到技术创新的显着影响，例如医疗保健基础设施的进步、外科手术的增加以及麻醉输送系统的发展。此外，对微创手术的需求不断增长，以及吸入麻醉剂与静脉注射麻醉剂相比的成本效益也带来了巨大的成长机会。然而，严格的监管核准、潜在的副作用以及温室气体排放的环境问题等挑战正在阻碍市场扩张。开发中地区的价格敏感度也增加了限制。

为了利用市场机会，鼓励公司专注研究和开发副作用更少、环境影响更小的新型麻醉剂。强调对医疗保健提供者进行关于这些药物的安全使用和处理的教育可以提高市场渗透率。此外，与医疗组织合作并进入外科手术需求量大的区域市场可以提供利润丰厚的成长途径。创新技术包括优化给药效率和环境足迹的药物传输系统。总体而言，儘管存在监管和环境挑战，但市场竞争激烈，医疗实践和技术的进步推动了市场成长。

市场动态：揭示快速发展的吸入麻醉剂市场的关键市场洞察

供需的动态交互作用正在改变吸入麻醉剂市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助企业了解消费行为及其对製造业的影响。

  • 市场驱动因素
    • 全球手术和慢性病数量的增加以及对微创治疗的需求
    • 政府对外科手术的核准和报销政策优惠
  • 市场限制因素
    • 与吸入麻醉剂产品召回相关的潜在风险
  • 市场机会
    • 整合有效的奈米药物输送系统用于吸入麻醉剂
    • 投资合成和麻醉剂鸦片类麻醉剂的研发
  • 市场挑战
    • 与吸入麻醉剂相关的副作用

波特五力：驾驭吸入麻醉剂市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解吸入麻醉剂市场的外部影响

外部宏观环境因素在塑造吸入麻醉剂市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解吸入麻醉剂市场的竞争状况

对吸入麻醉剂市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵吸入麻醉剂市场供应商的绩效评估

FPNV 定位矩阵是评估吸入麻醉剂市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议，以规划吸入麻醉剂市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对吸入麻醉剂市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 世界各地的手术和慢性病数量不断增加，增加了对微创治疗方案的需求。
      • 政府对外科手术的核准和报销政策优惠
    • 抑制因素
      • 与吸入麻醉剂产品召回相关的潜在风险
    • 机会
      • 整合有效的奈米药物输送系统用于吸入麻醉剂
      • 投资合成和非鸦片类麻醉剂的研发
    • 任务
      • 与吸入麻醉剂相关的副作用
  • 市场区隔分析
    • 类型：DESFLURANE因其具有快速恢復、可预测性和头脑清晰的优点而被用作麻醉剂。
    • 应用：在复杂的手术过程中越来越多地使用吸入麻醉剂来控制疼痛
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章吸入麻醉剂市场：依类型

  • DESFLURANE
  • 氟烷
  • Isoflurane
  • 氧化亚氮
  • SEVOFLURANE

第七章吸入麻醉剂市场按作用持续时间

  • 长效
  • 短效

第八章吸入麻醉剂市场：依应用分类

  • 诊断程序
  • 紧急护理
  • 外科手术
    • 心血管外科
    • 一般外科
    • 妇科手术
    • 神经外科
    • 整形外科

第九章吸入麻醉剂市场：依最终用途

  • 门诊手术中心
  • 医院

第十章美洲吸入麻醉剂市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太吸入麻醉剂市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲吸入麻醉剂市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • AANA 发布麻醉气体废弃物安全处置新指南
    • Benenden 医院采用 Sage Tech Medical 的环保麻醉气体回收技术
  • 战略分析和建议

公司名单

  • AbbVie Inc.
  • Aesica Queenborough Limited
  • Akorn, Inc.
  • Aspen Pharmacare Holdings Limited
  • Baxter International Inc.
  • BOC Healthcare
  • Draegerwerk AG & Co. KGaA
  • Eagle Pharmaceuticals
  • Fresenius Kabi AG
  • GE HealthCare Technologies, Inc.
  • Halocarbon Life Sciences
  • Hikma Pharmaceuticals PLC
  • Intersurgical Ltd
  • Jiangsu Hengrui Medicine Co., Ltd.
  • Linde PLC
  • Lunan Pharmaceutical Group Co. Ltd.
  • Maruishi Pharmaceutical Co., Ltd.
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer Inc.
  • Piramal Enterprises Limited
  • Teligent, Inc.
  • Troikaa Pharmaceuticals Ltd.
  • Vigon International Inc.
  • Yichang Humanwell Pharmaceutical Co., Ltd.
  • Zoetis Inc.
Product Code: MRR-742BD517FC4B

The Inhalation Anesthetics Market was valued at USD 1.70 billion in 2023, expected to reach USD 1.88 billion in 2024, and is projected to grow at a CAGR of 11.01%, to USD 3.54 billion by 2030.

The inhalation anesthetics market encompasses a range of gaseous agents used primarily for the induction and maintenance of general anesthesia during surgical procedures. These agents include sevoflurane, desflurane, and isoflurane, among others, and are integral in ensuring patient immobilization, amnesia, and analgesia. The necessity for inhalation anesthetics is underscored by the growing number of surgical procedures globally, driven by an aging population and the increasing prevalence of chronic diseases such as cardiovascular disorders and cancer. Beyond hospitals and ambulatory surgical centers, these anesthetics are increasingly being utilized in dental procedures, veterinary surgeries, and outpatient settings, thus expanding their end-use scope.

KEY MARKET STATISTICS
Base Year [2023] USD 1.70 billion
Estimated Year [2024] USD 1.88 billion
Forecast Year [2030] USD 3.54 billion
CAGR (%) 11.01%

Market growth is significantly influenced by advancements in healthcare infrastructure, a rise in surgical procedures, and technological innovations like the development of anesthesia delivery systems. Additionally, the growing demand for minimally invasive surgeries and the cost-effectiveness of inhalation anesthetics compared to intravenous alternatives present substantial growth opportunities. However, challenges such as stringent regulatory approvals, potential side effects, and environmental concerns related to greenhouse gas emissions hinder market expansion. Price sensitivity in developing regions also adds to the limitations.

To capitalize on market opportunities, companies are advised to focus on research and development of newer anesthetic agents with reduced side effects and lower environmental impact. Emphasizing education for healthcare providers regarding the safe use and handling of these agents can enhance market penetration. Furthermore, partnerships with medical associations and participation in regional markets with high surgical demand can offer lucrative growth avenues. Innovations could target drug delivery systems that optimize dosing efficiency and environmental footprint. Overall, the market is competitive but poised for growth, driven by evolving medical practices and technology, despite underlying regulatory and environmental challenges.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Inhalation Anesthetics Market

The Inhalation Anesthetics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rise in the number of surgeries and chronic diseases globally and the need for minimally invasive treatment options
    • Favorable government approvals and reimbursement policies for surgical procedures
  • Market Restraints
    • Potential risk associated with the product recall of inhalation anesthetic drugs
  • Market Opportunities
    • Integration of nano-based drug delivery systems for effective inhalation anesthetics
    • Investment in R&D for synthetic and non-opioid anesthetics
  • Market Challenges
    • Side effects associated with inhalation anesthetic drugs

Porter's Five Forces: A Strategic Tool for Navigating the Inhalation Anesthetics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Inhalation Anesthetics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Inhalation Anesthetics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Inhalation Anesthetics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Inhalation Anesthetics Market

A detailed market share analysis in the Inhalation Anesthetics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Inhalation Anesthetics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Inhalation Anesthetics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Inhalation Anesthetics Market

A strategic analysis of the Inhalation Anesthetics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Inhalation Anesthetics Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Aesica Queenborough Limited, Akorn, Inc., Aspen Pharmacare Holdings Limited, Baxter International Inc., BOC Healthcare, Draegerwerk AG & Co. KGaA, Eagle Pharmaceuticals, Fresenius Kabi AG, GE HealthCare Technologies, Inc., Halocarbon Life Sciences, Hikma Pharmaceuticals PLC, Intersurgical Ltd, Jiangsu Hengrui Medicine Co., Ltd., Linde PLC, Lunan Pharmaceutical Group Co. Ltd., Maruishi Pharmaceutical Co., Ltd., Merck & Co., Inc., Novartis AG, Pfizer Inc., Piramal Enterprises Limited, Teligent, Inc., Troikaa Pharmaceuticals Ltd., Vigon International Inc., Yichang Humanwell Pharmaceutical Co., Ltd., and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the Inhalation Anesthetics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Desflurane, Halothane, Isoflurane, Nitrous Oxide, and Sevoflurane.
  • Based on Duration of Action, market is studied across Long-acting and Short-acting.
  • Based on Application, market is studied across Diagnostic Procedures, Emergency Care, and Surgical Procedures. The Surgical Procedures is further studied across Cardiovascular Surgery, General Surgery, Gynecological Surgery, Neurosurgery, and Orthopedic Surgery.
  • Based on End Use, market is studied across Ambulatory Surgical Centers and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rise in the number of surgeries and chronic diseases globally and the need for minimally invasive treatment options
      • 5.1.1.2. Favorable government approvals and reimbursement policies for surgical procedures
    • 5.1.2. Restraints
      • 5.1.2.1. Potential risk associated with the product recall of inhalation anesthetic drugs
    • 5.1.3. Opportunities
      • 5.1.3.1. Integration of nano-based drug delivery systems for effective inhalation anesthetics
      • 5.1.3.2. Investment in R&D for synthetic and non-opioid anesthetics
    • 5.1.4. Challenges
      • 5.1.4.1. Side effects associated with inhalation anesthetic drugs
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Utilization of Desflurane in anesthetics due to its advantage in rapid, predictable, and clear-headed recovery
    • 5.2.2. Application: Increasing usage of inhalation anesthetics for pain management in complex surgery process
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Inhalation Anesthetics Market, by Type

  • 6.1. Introduction
  • 6.2. Desflurane
  • 6.3. Halothane
  • 6.4. Isoflurane
  • 6.5. Nitrous Oxide
  • 6.6. Sevoflurane

7. Inhalation Anesthetics Market, by Duration of Action

  • 7.1. Introduction
  • 7.2. Long-acting
  • 7.3. Short-acting

8. Inhalation Anesthetics Market, by Application

  • 8.1. Introduction
  • 8.2. Diagnostic Procedures
  • 8.3. Emergency Care
  • 8.4. Surgical Procedures
    • 8.4.1. Cardiovascular Surgery
    • 8.4.2. General Surgery
    • 8.4.3. Gynecological Surgery
    • 8.4.4. Neurosurgery
    • 8.4.5. Orthopedic Surgery

9. Inhalation Anesthetics Market, by End Use

  • 9.1. Introduction
  • 9.2. Ambulatory Surgical Centers
  • 9.3. Hospitals

10. Americas Inhalation Anesthetics Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Inhalation Anesthetics Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Inhalation Anesthetics Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. AANA issues new guidelines for safe disposal of waste anesthetic gases
    • 13.3.2. Benenden Hospital adopts SageTech Medical's eco-friendly anesthetic gas recycling technology
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AbbVie Inc.
  • 2. Aesica Queenborough Limited
  • 3. Akorn, Inc.
  • 4. Aspen Pharmacare Holdings Limited
  • 5. Baxter International Inc.
  • 6. BOC Healthcare
  • 7. Draegerwerk AG & Co. KGaA
  • 8. Eagle Pharmaceuticals
  • 9. Fresenius Kabi AG
  • 10. GE HealthCare Technologies, Inc.
  • 11. Halocarbon Life Sciences
  • 12. Hikma Pharmaceuticals PLC
  • 13. Intersurgical Ltd
  • 14. Jiangsu Hengrui Medicine Co., Ltd.
  • 15. Linde PLC
  • 16. Lunan Pharmaceutical Group Co. Ltd.
  • 17. Maruishi Pharmaceutical Co., Ltd.
  • 18. Merck & Co., Inc.
  • 19. Novartis AG
  • 20. Pfizer Inc.
  • 21. Piramal Enterprises Limited
  • 22. Teligent, Inc.
  • 23. Troikaa Pharmaceuticals Ltd.
  • 24. Vigon International Inc.
  • 25. Yichang Humanwell Pharmaceutical Co., Ltd.
  • 26. Zoetis Inc.

LIST OF FIGURES

  • FIGURE 1. INHALATION ANESTHETICS MARKET RESEARCH PROCESS
  • FIGURE 2. INHALATION ANESTHETICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL INHALATION ANESTHETICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS INHALATION ANESTHETICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS INHALATION ANESTHETICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES INHALATION ANESTHETICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES INHALATION ANESTHETICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC INHALATION ANESTHETICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC INHALATION ANESTHETICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA INHALATION ANESTHETICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA INHALATION ANESTHETICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. INHALATION ANESTHETICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. INHALATION ANESTHETICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. INHALATION ANESTHETICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL INHALATION ANESTHETICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. INHALATION ANESTHETICS MARKET DYNAMICS
  • TABLE 7. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY DESFLURANE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY HALOTHANE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY ISOFLURANE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY NITROUS OXIDE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY SEVOFLURANE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY LONG-ACTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY SHORT-ACTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY EMERGENCY CARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY GYNECOLOGICAL SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY NEUROSURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS INHALATION ANESTHETICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES INHALATION ANESTHETICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC INHALATION ANESTHETICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. AUSTRALIA INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 71. AUSTRALIA INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. CHINA INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 76. CHINA INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. INDIA INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 81. INDIA INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. INDONESIA INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 86. INDONESIA INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. JAPAN INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 91. JAPAN INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. MALAYSIA INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 96. MALAYSIA INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. PHILIPPINES INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 101. PHILIPPINES INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. SINGAPORE INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 106. SINGAPORE INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. SOUTH KOREA INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 111. SOUTH KOREA INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. TAIWAN INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 116. TAIWAN INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. THAILAND INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 121. THAILAND INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. VIETNAM INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 126. VIETNAM INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA INHALATION ANESTHETICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. DENMARK INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 137. DENMARK INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. EGYPT INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 142. EGYPT INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. FINLAND INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 147. FINLAND INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 151. FRANCE INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 152. FRANCE INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 156. GERMANY INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 157. GERMANY INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 161. ISRAEL INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 162. ISRAEL INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 166. ITALY INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 167. ITALY INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 171. NETHERLANDS INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 172. NETHERLANDS INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 176. NIGERIA INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 177. NIGERIA INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 181. NORWAY INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 182. NORWAY INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 186. POLAND INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 187. POLAND INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 191. QATAR INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 192. QATAR INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 196. RUSSIA INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 197. RUSSIA INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 201. SAUDI ARABIA INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 202. SAUDI ARABIA INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH AFRICA INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 207. SOUTH AFRICA INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 211. SPAIN INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 212. SPAIN INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 216. SWEDEN INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 217. SWEDEN INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 221. SWITZERLAND INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 222. SWITZERLAND INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 226. TURKEY INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 227. TURKEY INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED ARAB EMIRATES INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED ARAB EMIRATES INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED KINGDOM INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 237. UNITED KINGDOM INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 238. INHALATION ANESTHETICS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 239. INHALATION ANESTHETICS MARKET, FPNV POSITIONING MATRIX, 2023